Why the study?
Although the link between CVD and various cancers is well established, the relationship between CVD risk and colorectal cancer remains underexplored.
Does the presence of cardiovascular disease increase the risk of incident cancer in adults?
Does the presence of cardiovascular disease increase the risk of incident cancer in adults?
Cardiovascular disease, particularly atherosclerotic CVD, is independently associated with an increased risk of incident cancer, suggesting a need for heightened cancer awareness in this population.
Should not yet change CRC screening; leaves open whether CV risk scores can stratify young-onset CRC risk in males.
BACKGROUND Although the link between cardiovascular disease (CVD) and various cancers is well-established, the relationship between CVD risk and colorectal cancer (CRC) remains underexplored. AIM To elucidate the relationship between CVD risk scores and CRC incidence. METHODS In this population-based cohort study, participants from the 2009 National Health Checkup were followed-up until 2020. The cardiovascular (CV) risk score was calculated as the sum of risk factors (age, family history of coronary artery disease, hypertension, smoking status, and high-density lipoprotein levels) with high-density lipoprotein (≥ 60 mg/dL) reducing the risk score by one. The primary outcome was incidence of newly diagnosed CRC. RESULTS Among 2526628 individuals, 30329 developed CRC during a mean follow-up of 10.1 years. Categorized by CV risk scores (0, 1, 2, and ≥ 3). CRC risk increased with higher CV risk scores after adjusting for covariates [(hazard ratio = 1.155, 95% confidence interval: 1.107-1.205) in risk score ≥ 3, P < 0.001]. This association was exclusively observed in males, most notably in the younger cohort (< 50 years) and was more pronounced in individuals not using statins. Moreover, even in participants without diabetes, a higher CV risk was associated with an increased CRC risk. CONCLUSION Increased CV risk scores were significantly associated with higher CRC risk, especially among males, younger populations, and non-statin users. Thus, males with a higher CV risk score, even at a younger age, are recommended to control their risk factors and undergo individualized CRC screening.
No takes yet. Share an insight, caveat, or question.
Song et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: